OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Muna Al-Khaifi Explores How Exercise Improves Outcomes in Breast Cancer

Highlights from BCANTT26 Shared by Petros Grivas

Bishal Gyawali: The King Has Been Dethroned in Pivotal Oncology Trials

Expanding Access to Lung Cancer Screening and Early Detection Worldwide – Bristol Myers Squibb

BTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives

Oncology News, Insights, Stories by OncoDaily

TROPION-Breast01
Breast Oncology

TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes

FDA
Science

Discussions Around FDA Approval of Pluvicto for PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

Maryam Lustberg
Science

Maryam Lustberg: New ASCO Guideline Introduces Risk-Based Breast Cancer Follow-Up

Neil Ranasinghe: Colombo-Cambridge Children’s Cancer Collaboration

BOND-003 Phase 3: Cretostimogene Shows 75% Complete Response Rate in BCG-Unresponsive NMIBC

Franco Baresi Dies at 66: AC Milan and Italian Football Mourn an Iconic Legend

Top 10 GU Oncology Updates – July 2026

Patrick Soon-Shiong: So Excited That UAE EDE Took the Lead to Authorize the Broadest Aproval for ANKTIVA

Andrea Necchi: Our First Network Meta-Analysis of Perioperative Trials in MIBC

Bishal Gyawali։ New Episode of Grounded in Groundshot Podcast With Chris Booth

Voices
Megan Sanders

Megan Sanders: Consultation Webinar on the Medical Research Future Fund Strategy and Priorities

Jonathan Cohen: Returning to Hadassah Medical Center as Director of Oncology Clinical Research

Matt Sherer: Why Rural Oncology Access Depends on Building Better Care Networks

Felicia Marie Knaul։ Exploring the Healing Power of Therapeutic Riding

A Historic Day for Zambia With New Radiotherapy and Imaging Facility - Zambian Cancer Society

Rui Medeiros: 3 Powerful Insights From the Groundbreaking Future of Precision Cancer Education

Sarbajit Mukherjee: Innovative ctDNA 2.0 Could Transform Precision Oncology

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Benign Hematology and Thrombosis: 2026 Emerging Therapies - MSK

Memorial Sloan Kettering Cancer Center (MSK)

16 Oct
Benign Hematology

The 14th International Symposium on Hodgkin Lymphoma (ISHL14)

German Hodgkin Study Group (GHSG)

03 Oct
Hodgkin Lymphoma

TACOS 2026 Advancing Oncology Summit

The Arizona Clinical Oncology Society (TACOS)

07 Nov
TACOS 2026

28th Annual Blood-Brain Barrier Consortium

Providence Neuroscience Institute

15 Oct
Blood-Brain Barrier

Immune-Related Adverse Events Webinar Series: Pneumonitis - Fred Hutch Cancer Center

Fred Hutch Cancer Center

30 Sep
Pneumonitis

Immune-oncology
Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

CRISPR in Cancer Immunotherapy and Precision Oncology

Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Artificial Intelligence in Cancer Immunotherapy

Can ctDNA Predict Both Benefit and Toxicity From Immunotherapy?

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Gastrointestinal-Oncology
ctDNA

ctDNA in Gastrointestinal Cancers: What the Evidence Shows

DESTINY-PanTumor02: T-DXd in HER2-Expressing Biliary Tract or Pancreatic Cancers

10 Must-Read Posts In GI Oncology This Week

Claudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer

FIND Trial: ctDNA-Guided Surveillance After Curative-Intent Colorectal Cancer Surgery

ESMO GI 2026 Hepatobiliary Cancer Highlights: From TACE Combinations to Precision Cholangiocarcinoma Treatment

Liver Cancer: How Dose Distribution Shapes 90Y-SIRT Outcomes

Breast-Oncology
FeDeriCa

FeDeriCa: 4-Year Outcomes Support Subcutaneous HER2 Therapy

TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes

EVERGREEN Study: Everolimus Shows Modest Benefit After CDK4/6 Progression

HER2-Low and HER2-Ultralow: What the Categories Change in Practice

Should Brain MRI Screening Expand in Metastatic Breast Cancer?

Breast Cancer in Gender-Diverse Patients: Younger Age, Frequent Self-Detection, and Favorable Short-Term Survival

RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer

Lung-Oncology
Nonsmoking Individuals

Lung Cancer in Nonsmoking Individuals: A Distinct Clinical Profile

TREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC

Phase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD

89 Experts Map Key Gray Zones in Non-Metastatic NSCLC

Molecular Testing Turnaround Before First-Line Therapy in Advanced NSCLC

Ivonescimab Improves Survival After EGFR-TKI Failure

INTEGRAL-Risk May Refine Lung Cancer Screening Eligibility

Oncology Tech
Personalis

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

Hematology
BTK inhibitors CLL

BTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives

Systemic Mastocytosis: A Hematologic Neoplasm Often Mistaken for Allergy and Other Conditions

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Radiotherapy
Nodal Radiotherapy

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

IMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases

Shorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer

Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer

10 Must-Read Posts In Radiotherapy This Week: July 20-26

OncoDaily TV
The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Not To Miss
BIGR: top growing medical universities in the world

Top Growing Medical Universities in the Wold: 2026 Edition by BIGR

15 Posts Not To Miss From the 2026 Bladder Cancer Advocacy Network Think Tank

Community Oncology Global Congress 2026: Bringing Cancer Care Closer to Where Patients Live

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

OncoGrants
Lung Cancer Research

FY26 Lung Cancer Research Program Idea Development Award

Patient-Centered Outcomes

FY26 Lung Cancer Patient-Centered Outcomes and Survivorship Award

Melanoma

FY26 Melanoma Research Program Idea Award

Melanoma

FY26 Melanoma Research Program Academy Scholar Award

Kidney Cancer Research

FY26 Kidney Cancer Research Program Idea Development Award

Kidney Cancer

Kidney Cancer Early-Career Scholar Award 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Sanjay Juneja

Sanjay Juneja

Oncologists Location Baton Rouge, USA
Javier David Benítez

Javier David Benítez

Oncologists Location Elche, Spain
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Dinesh Pendharkar

Dinesh Pendharkar

Oncologists Location Faridabad, India
Uddiptya Goswami

Uddiptya Goswami

Oncologists Location Thiruvananthapuram, India
Helena Kremer

Helena Kremer

Oncologists Location Rio de Janeiro, Brazil
Maite Gorostegui Obanos

Maite Gorostegui Obanos

Oncologists Location Barcelona, Spain
Anjaly Mohan

Anjaly Mohan

Oncologists Location Thiruvananthapuram, India

Oncology Drugs
DKN-01

DKN-01: Promising DKK1-Targeted Therapy, Dose, Administration, and Clinical Trials

Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews